Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
MS Cardiologie from Verlaine, company number BE0723716604, closed financial year 2025 with a result of € 150,815 after tax. For that financial year MS Cardiologie recorded a gross margin of € 229,061 and equity of € 163,215. Compared with financial year 2024, the result moved from € 135,758 to € 150,815. Profitable, and profit is growing. The buffer shrank hard: equity is 55 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 163,215
▼ 55% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 150,815
▲ 11% vs 2024
Profit after tax over the fiscal year.
€ 464,571
▲ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 351,273 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 2,229
▼ 6% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 660
▲ 54% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 91,972
▲ 33% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 184,680 | € 146,190 | € 194,132 | € 229,061 | ▲ 18% |
| Profit after taxes | € 127,517 | € 111,834 | € 135,758 | € 150,815 | ▲ 11% |
| Equity | € 363,673 | € 363,673 | € 363,673 | € 163,215 | ▼ 55% |
| Total debts | € 115,235 | € 142,326 | € 184,911 | € 422,595 | ▲ 129% |
| Cash | € 321,858 | € 390,576 | € 445,662 | € 464,571 | ▲ 4% |
| Retained profit | € 351,273 | € 351,273 | € 351,273 | € 150,815 | ▼ 57% |
| Dividend | € 0 | € 111,834 | € 135,758 | € 351,273 | ▲ 159% |
| Balance sheet total | € 478,909 | € 506,000 | € 548,584 | € 585,809 | ▲ 7% |
Key figures of MS Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MS Cardiologie?
What happened at MS Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Stella MARCHETTA stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 150,815 (▲ 11% vs 2024). filed late Source: NBB ↗
- Ludovic MOUTSCHEN became a director. NBB
- New establishment in Verlaine. KBO
- Stella MARCHETTA became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 127,517 profit in 2022 to € 150,815 profit in 2025.
Paid € 197,320 in corporate taxes since 2022.
Best year ever: 2025, with € 150,815 profit.
Paid out € 598,865 in dividends to the owners in total.
Management
Behind MS Cardiologie is Ludovic MOUTSCHEN.
Directors
According to the 2025 annual accounts
Ludovic MOUTSCHEN
Director
since 2025
Stella MARCHETTA
Director
since 2019 · until 2039
Establishments
Establishment units
Physical locations of this company
Rue Trixhelette(BOD) 39
4537 Verlaine
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0723.716.604
- VAT number
- BE 0723.716.604
- Registered office
- Rue Trixhelette(BOD) 39, 4537 Verlaine
- Names & denominations
- MS Cardiologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 March 2019
- Peppol
- Not registered